These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16135168)
1. A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer. Goksel T; Hatipoglu ON; Ozturk C; Gorguner M; Kiyik M; Yilmaz U; Guzelant A; Tasbakan S; Tabakoglu E; Firat H; Tutar U; Cikrikicioglu S; Akkoclu A; Soyer S; Cakir E; Itil O; Sanal S Respirology; 2005 Sep; 10(4):456-63. PubMed ID: 16135168 [TBL] [Abstract][Full Text] [Related]
2. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group. Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757 [TBL] [Abstract][Full Text] [Related]
3. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. Cardenal F; López-Cabrerizo MP; Antón A; Alberola V; Massuti B; Carrato A; Barneto I; Lomas M; García M; Lianes P; Montalar J; Vadell C; González-Larriba JL; Nguyen B; Artal A; Rosell R J Clin Oncol; 1999 Jan; 17(1):12-8. PubMed ID: 10458212 [TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale. Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G; Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. Comella P; Frasci G; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Micillo E; Lorusso V; Di Rienzo G; Filippelli G; Lamberti A; Natale M; Bilancia D; Nicolella G; Di Nota A; Comella G J Clin Oncol; 2000 Apr; 18(7):1451-7. PubMed ID: 10735892 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Brodowicz T; Krzakowski M; Zwitter M; Tzekova V; Ramlau R; Ghilezan N; Ciuleanu T; Cucevic B; Gyurkovits K; Ulsperger E; Jassem J; Grgic M; Saip P; Szilasi M; Wiltschke C; Wagnerova M; Oskina N; Soldatenkova V; Zielinski C; Wenczl M; Lung Cancer; 2006 May; 52(2):155-63. PubMed ID: 16569462 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer. Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma. Mok TS; Zee B; Chan AT; Yeo W; Yang WT; Yim A; Leung SF; Nguyen B; Leung TW; Johnson P Cancer; 2000 Aug; 89(3):543-50. PubMed ID: 10931453 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience. Kim JH; Kim SY; Jung KH; Park K; Suh CW; Lim HY; Kim YH; Ryoo BY; Cho EK; Park BJ; Heo DS Lung Cancer; 2006 Apr; 52(1):75-81. PubMed ID: 16488054 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group. Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Manzione L; Bilancia D; Cioffi R; Maiorino L; De Cataldis G; Belli M; Micillo E; Mascia V; Massidda B; Lorusso V; De Lena M; Carpagnano F; Contu A; Pusceddu G; Comella G J Clin Oncol; 1999 Aug; 17(8):2316-25. PubMed ID: 10561293 [TBL] [Abstract][Full Text] [Related]
11. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. Sandler AB; Nemunaitis J; Denham C; von Pawel J; Cormier Y; Gatzemeier U; Mattson K; Manegold C; Palmer MC; Gregor A; Nguyen B; Niyikiza C; Einhorn LH J Clin Oncol; 2000 Jan; 18(1):122-30. PubMed ID: 10623702 [TBL] [Abstract][Full Text] [Related]
12. Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer. ten Bokkel Huinink WW; Bergman B; Chemaissani A; Dornoff W; Drings P; Kellokumpu-Lehtinen PL; Liippo K; Mattson K; von Pawel J; Ricci S; Sederholm C; Stahel RA; Wagenius G; Walree NV; Manegold C Lung Cancer; 1999 Nov; 26(2):85-94. PubMed ID: 10568679 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224 [TBL] [Abstract][Full Text] [Related]
14. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer. Kontopodis E; Kotsakis A; Kentepozidis N; Syrigos K; Ziras N; Moutsos M; Filippa G; Mala A; Vamvakas L; Mavroudis D; Georgoulias V; Agelaki S Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909 [TBL] [Abstract][Full Text] [Related]
15. Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. Gridelli C; Gallo C; Ceribelli A; Gebbia V; Gamucci T; Ciardiello F; Carozza F; Favaretto A; Daniele B; Galetta D; Barbera S; Rosetti F; Rossi A; Maione P; Cognetti F; Testa A; Di Maio M; Morabito A; Perrone F; Lancet Oncol; 2007 Jun; 8(6):500-12. PubMed ID: 17513173 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. Alberola V; Camps C; Provencio M; Isla D; Rosell R; Vadell C; Bover I; Ruiz-Casado A; Azagra P; Jiménez U; González-Larriba JL; Diz P; Cardenal F; Artal A; Carrato A; Morales S; Sanchez JJ; de las Peñas R; Felip E; López-Vivanco G; J Clin Oncol; 2003 Sep; 21(17):3207-13. PubMed ID: 12947054 [TBL] [Abstract][Full Text] [Related]
17. A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study. Rossi D; Graziano F; Catalano V; Giordani P; Fedeli SL; Alessandroni P; Fedeli A; Dennetta D; Ugolini M; Catalano G Anticancer Res; 2002; 22(5):3087-92. PubMed ID: 12530048 [TBL] [Abstract][Full Text] [Related]
18. Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer. Mok TS; Lam KC; Lee C; Zhang L; Wong H; Chan AT; Yeo W; Yim AP; Chak K; Zee B Oncology; 2005; 68(4-6):485-92. PubMed ID: 16020979 [TBL] [Abstract][Full Text] [Related]
19. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC). Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086 [TBL] [Abstract][Full Text] [Related]
20. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. Masters GA; Argiris AE; Hahn EA; Beck JT; Rausch PG; Ye Z; Monberg MJ; Bloss LP; Curiel RE; Obasaju CK J Thorac Oncol; 2006 Jan; 1(1):19-24. PubMed ID: 17409822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]